M.I. Lerman
- Molecular Biology top 5%
- Cancer Research top 10%
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Genetics
- Co-authors
- Alexander S. SpirinN.V. BelitsinaG. P. GeorgievFarida LatifYoshitaka SekidoAdi F. GazdarMikhail N. SmirnovO. P. Samarina
- Topics
- RNA and protein synthesis mechanisms (13 papers)RNA modifications and cancer (7 papers)DNA and Nucleic Acid Chemistry (4 papers)
- Partner nations
- United StatesRussiaUnited Kingdom
In The Last Decade
M.I. Lerman
38 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 1.3k
- Cancer Research 304
- Oncology 237
- Pulmonary and Respiratory Medicine 198
- Genetics 167
Countries citing papers authored by M.I. Lerman
This map shows the geographic impact of M.I. Lerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.I. Lerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.I. Lerman more than expected).
Fields of papers citing papers by M.I. Lerman
This network shows the impact of papers produced by M.I. Lerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.I. Lerman. The network helps show where M.I. Lerman may publish in the future.
Co-authorship network of co-authors of M.I. Lerman
This figure shows the co-authorship network connecting the top 25 collaborators of M.I. Lerman. A scholar is included among the top collaborators of M.I. Lerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.I. Lerman. M.I. Lerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppressionbreakdown → | 659 |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 170 | |
| 8 | 23 | |
| 9 | [Albumin mRNA from rat liver cells. Analysis of immunoadsorption of individual polyribosomes]. | 1 |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | The limiting effect of transfer RNA's on the rate of protein synthesis in cell extracts of rapidly growing tumors. | 3 |
| 15 | 3 | |
| 16 | 3 | |
| 17 | 5 | |
| 18 | 180 | |
| 19 | 14 | |
| 20 | 23 |
About M.I. Lerman
M.I. Lerman is a scholar working on Structural Biology, Cancer Research and Molecular Biology, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (13 papers), RNA modifications and cancer (7 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Cancer Research (304 citations), Molecular Biology (1.3k citations) and Oncology (237 citations). M.I. Lerman has collaborated with scholars based in United States, Russia and United Kingdom. Frequent co-authors include Alexander S. Spirin, N.V. Belitsina, G. P. Georgiev, Farida Latif, Yoshitaka Sekido, Adi F. Gazdar, Mikhail N. Smirnov, O. P. Samarina, Sabine Zöchbauer‐Müller and Éva Forgács. Their work appears in journals such as Nature, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.